In general, GLP-1s are intended for adults who: Have obesity or overweight (BMI of 30 or higher) Have a BMI above 27 and a related health condition like insulin resistance, prediabetes, type 2 diabetes, high blood pressure, or high cholesterol Have been unable to maintain weight loss through other means (e.g., diet and exercise) While GLP-1s have helped many achieve their weight-loss goals and support their metabolic health, they arent for everyone
However, Tirzepatide pushes the boundaries due to its fine results as a dual-receptor agonist and boosts metabolic performance beyond traditional results.
doi:10.1080/14756360802323720
In addition, a detailed medication history is necessary to identify any drugs or supplements that might contribute to liver injury, such as methotrexate, amiodarone, corticosteroids, valproic acid, 5-fluorouracil, irinotecan, among others [81]
semaglutide has gastrointestinal and pancreatitis warnings